annual SGA:
$125.83M+$9.33M(+8.01%)Summary
- As of today (July 27, 2025), NTLA annual SGA is $125.83 million, with the most recent change of +$9.33 million (+8.01%) on December 31, 2024.
- During the last 3 years, NTLA annual SGA has risen by +$54.73 million (+76.98%).
- NTLA annual SGA is now at all-time high.
Performance
NTLA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$29.01M-$3.44M(-10.59%)Summary
- As of today (July 27, 2025), NTLA quarterly SGA is $29.01 million, with the most recent change of -$3.44 million (-10.59%) on March 31, 2025.
- Over the past year, NTLA quarterly SGA has dropped by -$2.08 million (-6.70%).
- NTLA quarterly SGA is now -10.59% below its all-time high of $32.44 million, reached on December 31, 2024.
Performance
NTLA quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$8.43B-$525.91M(-6.65%)Summary
- As of today (July 27, 2025), NTLA TTM SGA is -$8.43 billion, with the most recent change of -$525.91 million (-6.65%) on March 31, 2025.
- Over the past year, NTLA TTM SGA has dropped by -$8.55 billion (-7117.16%).
- NTLA TTM SGA is now -38331.90% below its all-time high of -$21.94 million.
Performance
NTLA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
NTLA Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.0% | -6.7% | -7117.2% |
| 3 y3 years | +77.0% | +29.5% | -10000.0% |
| 5 y5 years | +206.5% | +156.4% | -10000.0% |
NTLA Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +77.0% | -10.6% | +31.1% | -169.8% | at low |
| 5 y | 5-year | at high | +206.5% | -10.6% | +174.5% | -563.2% | at low |
| alltime | all time | at high | +1419.1% | -10.6% | +2513.2% | <-9999.0% | at low |
NTLA Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $29.01M(-10.6%) | $123.75M(-1.7%) |
| Dec 2024 | $125.83M(+8.0%) | $32.44M(+6.4%) | $125.83M(+2.8%) |
| Sep 2024 | - | $30.50M(-4.1%) | $122.38M(+0.9%) |
| Jun 2024 | - | $31.79M(+2.3%) | $121.28M(+0.9%) |
| Mar 2024 | - | $31.09M(+7.2%) | $120.14M(+3.1%) |
| Dec 2023 | $116.50M(+29.0%) | $28.99M(-1.4%) | $116.50M(+4.8%) |
| Sep 2023 | - | $29.40M(-4.1%) | $111.13M(+7.0%) |
| Jun 2023 | - | $30.65M(+11.7%) | $103.87M(+8.9%) |
| Mar 2023 | - | $27.45M(+16.2%) | $95.35M(+5.6%) |
| Dec 2022 | $90.31M(+27.0%) | $23.63M(+6.7%) | $90.31M(+1.7%) |
| Sep 2022 | - | $22.14M(+0.1%) | $88.79M(+4.0%) |
| Jun 2022 | - | $22.13M(-1.2%) | $85.35M(+6.8%) |
| Mar 2022 | - | $22.40M(+1.3%) | $79.91M(+12.4%) |
| Dec 2021 | $71.10M(+61.0%) | $22.11M(+18.2%) | $71.10M(+19.0%) |
| Sep 2021 | - | $18.71M(+12.2%) | $59.75M(+15.8%) |
| Jun 2021 | - | $16.68M(+22.7%) | $51.61M(+11.1%) |
| Mar 2021 | - | $13.59M(+26.3%) | $46.45M(+5.2%) |
| Dec 2020 | $44.17M | $10.76M(+1.9%) | $44.17M(+4.2%) |
| Sep 2020 | - | $10.57M(-8.3%) | $42.38M(+5.3%) |
| Jun 2020 | - | $11.53M(+1.9%) | $40.25M(-3.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $11.31M(+26.0%) | $41.84M(+1.9%) |
| Dec 2019 | $41.06M(+27.6%) | $8.98M(+6.5%) | $41.06M(+0.7%) |
| Sep 2019 | - | $8.43M(-35.7%) | $40.79M(+0.4%) |
| Jun 2019 | - | $13.12M(+24.5%) | $40.63M(+15.0%) |
| Mar 2019 | - | $10.53M(+21.0%) | $35.32M(+9.7%) |
| Dec 2018 | $32.19M(+14.9%) | $8.71M(+5.3%) | $32.19M(-4.5%) |
| Sep 2018 | - | $8.27M(+6.0%) | $33.69M(+8.2%) |
| Jun 2018 | - | $7.80M(+5.4%) | $31.14M(+4.8%) |
| Mar 2018 | - | $7.41M(-27.5%) | $29.70M(+6.0%) |
| Dec 2017 | $28.02M(+66.8%) | $10.21M(+78.8%) | $28.02M(+22.2%) |
| Sep 2017 | - | $5.71M(-10.3%) | $22.93M(+4.6%) |
| Jun 2017 | - | $6.37M(+11.1%) | $21.92M(+13.7%) |
| Mar 2017 | - | $5.73M(+12.0%) | $19.28M(+14.8%) |
| Dec 2016 | $16.80M(+102.8%) | $5.12M(+8.8%) | $16.80M(+15.9%) |
| Sep 2016 | - | $4.71M(+26.2%) | $14.49M(+28.1%) |
| Jun 2016 | - | $3.73M(+14.9%) | $11.31M(+8.6%) |
| Mar 2016 | - | $3.25M(+15.6%) | $10.42M(+25.8%) |
| Dec 2015 | $8.28M | $2.81M(+83.5%) | $8.28M(+51.3%) |
| Sep 2015 | - | $1.53M(-46.0%) | $5.47M(+38.8%) |
| Jun 2015 | - | $2.83M(+155.2%) | $3.94M(+255.2%) |
| Mar 2015 | - | $1.11M | $1.11M |
FAQ
- What is Intellia Therapeutics, Inc. annual SGA?
- What is the all time high annual SGA for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. annual SGA year-on-year change?
- What is Intellia Therapeutics, Inc. quarterly SGA?
- What is the all time high quarterly SGA for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. quarterly SGA year-on-year change?
- What is Intellia Therapeutics, Inc. TTM SGA?
- What is the all time high TTM SGA for Intellia Therapeutics, Inc.?
- What is Intellia Therapeutics, Inc. TTM SGA year-on-year change?
What is Intellia Therapeutics, Inc. annual SGA?
The current annual SGA of NTLA is $125.83M
What is the all time high annual SGA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high annual SGA is $125.83M
What is Intellia Therapeutics, Inc. annual SGA year-on-year change?
Over the past year, NTLA annual SGA has changed by +$9.33M (+8.01%)
What is Intellia Therapeutics, Inc. quarterly SGA?
The current quarterly SGA of NTLA is $29.01M
What is the all time high quarterly SGA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high quarterly SGA is $32.44M
What is Intellia Therapeutics, Inc. quarterly SGA year-on-year change?
Over the past year, NTLA quarterly SGA has changed by -$2.08M (-6.70%)
What is Intellia Therapeutics, Inc. TTM SGA?
The current TTM SGA of NTLA is -$8.43B
What is the all time high TTM SGA for Intellia Therapeutics, Inc.?
Intellia Therapeutics, Inc. all-time high TTM SGA is -$21.94M
What is Intellia Therapeutics, Inc. TTM SGA year-on-year change?
Over the past year, NTLA TTM SGA has changed by -$8.55B (-7117.16%)